tak-981
Showing 1 - 4 of 4
Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)
Recruiting
- Neoplasms
- +2 more
- TAK-981
-
La Jolla, California
- +15 more
Dec 7, 2022
Advanced or Metastatic Solid Tumors Trial in United States (TAK-981, Pembrolizumab)
Recruiting
- Advanced or Metastatic Solid Tumors
- TAK-981
- Pembrolizumab
-
Scottsdale, Arizona
- +10 more
Jan 26, 2022
Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial in United States (TAK-981, Mezagitamab, Daratumumab and
Recruiting
- Relapsed and/or Refractory Multiple Myeloma (RRMM)
- TAK-981
- +2 more
-
Scottsdale, Arizona
- +11 more
Jan 6, 2022
Lymphoma, Non-Hodgkin Trial in Worldwide (TAK-981, Rituximab)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- TAK-981
- Rituximab
-
Birmingham, Alabama
- +58 more
Dec 7, 2022